News
![Leap_Therapeutics_DKN-01](https://pharmaphorum.com/wp-content/uploads/2020/09/Leap_Therapeutics_DKN-01.jpg)
FDA fast-tracks Leap’s gastric cancer immunotherapy
Leap Therapeutics will get a swift FDA review for its lead drug DKN-01 for a form of gastric and gastroesophageal junction (G/GEJ) cancer after being awarded fast-track status by the regula